Antihypertensive Drug Therapy in Saskatchewan
Authors:
- Bruno RainvilleBRBruno Rainville
- Samy SuissaSSSamy Suissa
Open Access
- 13 August 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (15) , 1873-1879
Abstract
SUBOPTIMAL treatment of uncomplicated hypertension constitutes a major barrier to effective therapy. Early discontinuation and erratic drug use manifested by frequent interruptions and switches to different treatment regimens have been shown to be associated with the progression of cardiovascular and renal diseases, and to increase the risk of a readmission to the hospital.1-8Keywords
This publication has 13 references indexed in Scilit:
- Health Databases in Saskatchewan2000
- The direct costs to the NHS of discontinuing and switching prescriptions for hypertensionJournal of Human Hypertension, 1998
- The Clinical and Economic Implications of Drug Utilization Patterns in the Treatment of Hypertension with ACE Inhibitors and Calcium Channel Blockers in a Managed Care SettingJournal of Managed Care Pharmacy, 1998
- Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blockerClinical Therapeutics, 1997
- Variations in compliance among hypertensive patients by drug class: implications for health care costsClinical Therapeutics, 1997
- The costs and effects of switching calcium channel blockers: evidence from Medicaid claims dataClinical Therapeutics, 1995
- The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid PopulationMedical Care, 1994
- Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study1993
- The Relative Risk of Incident Coronary Heart Disease Associated With Recently Stopping the Use of β-BlockersJAMA, 1990
- Underutilization of Antihypertensive Drugs and Associated HospitalizationMedical Care, 1989